Skip to main content
TipRanks
Go Ultimate75% OFF

Quoin Pharmaceuticals (QNRX) Drug Pipeline

398 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Qrx003Netherton Syndromephase2AndPhase3RecruitingPhase 2/3 Clinical Study of QRX003 Lotion in Subjects With Netherton SyndromeMar 24, 2026―
Qrx003, 4% LotionNetherton Syndromephase2AndPhase3RecruitingClinical Study of QRX003 Lotion in Subjects With Netherton SyndromeApr 07, 2025
Qrx003, 4% LotionNetherton Syndromephase2AndPhase3RecruitingOpen Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Netherton SyndromeMar 16, 2023
Vehicle, Qrx003-2% Lotion, Qrx003-4% Lotion Qam, Qrx003-4% Lotion BidNetherton Syndromephase2AndPhase3RecruitingSafety, Tolerability and Efficacy of QRX003 Lotion in Subjects With Netherton SyndromeAug 17, 2022

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Quoin Pharmaceuticals Ltd (QNRX) have in its pipeline
Quoin Pharmaceuticals QNRX is currently developing the following drugs: Qrx003, Qrx003, 4% Lotion, Vehicle, Qrx003-2% Lotion, Qrx003-4% Lotion Qam, Qrx003-4% Lotion Bid. These drug candidates are in various stages of clinical development as the company works toward FDA approval.